Page 35 - லயோலா பல்கலைக்கழகம் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brachytherapy may proceed safely in cervical cancer patients following uterine perforation A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation. According to the World Health Organization, cervical cancer is the fourth most common cancer in women. Treatment for cervical cancer often involves brachytherapy combined with daily radiation therapy. Brachytherapy delivers radiation directly to cancer cells through a tube placed within the uterus. At times this tube can pierce the uterus and lead to a perforation. Many clinicians will not proceed with the treatment when a perforation occurs. This can lead to delays in therapy that may increase the recurrence risk and potentially lead to worse survival rates.

Emily hendersonLoyola university chicago stritch school of medicineWorld health organizationLoyola university medical centerLoyola cardinal bernardin cancer centerLoyola medicineLoyola university chicago stritch schoolLoyola university medicalNational cancer instituteCommon terminology criteriaAdverse events versionCardinal bernardin cancerCervical cancerNext generationRadiation therapyஎமிலி ஹென்டர்சன்